BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27811505)

  • 1. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Nell S; Borel Rinkes IHM; Verkooijen HM; Bonsing BA; van Eijck CH; van Goor H; de Kleine RHJ; Kazemier G; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; Vriens MR;
    Ann Surg; 2018 Feb; 267(2):352-356. PubMed ID: 27811505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.
    Nell S; Verkooijen HM; Pieterman CRC; de Herder WW; Hermus AR; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Ann Surg; 2018 Jun; 267(6):1155-1160. PubMed ID: 28257328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
    Klein Haneveld MJ; van Treijen MJC; Pieterman CRC; Dekkers OM; van de Ven A; de Herder WW; Zandee WT; Drent ML; Bisschop PH; Havekes B; Vriens MR; Verrijn Stuart AA; Valk GD; van Leeuwaarde RS
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3515-3525. PubMed ID: 34333645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort.
    van Beek DJ; Nell S; Vorselaars WMCM; Bonsing BA; van Eijck CHJ; van Goor H; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; ; Borel Rinkes IHM; Vriens MR
    Ann Surg Oncol; 2021 Aug; 28(8):4387-4399. PubMed ID: 33521900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
    Sadowski SM; Pieterman CRC; Perrier ND; Triponez F; Valk GD
    Endocr Relat Cancer; 2020 Jun; 27(6):R145-R161. PubMed ID: 32229700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1.
    Conrad C; Schwarz L; Perrier N; Fleming JB; Katz MH; Aloia TA; Vauthey JN; Lee JE
    Surg Endosc; 2016 Oct; 30(10):4619. PubMed ID: 26721691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Surveillance versus Surgery of Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤2 cm in MEN1 Patients.
    Partelli S; Tamburrino D; Lopez C; Albers M; Milanetto AC; Pasquali C; Manzoni M; Toumpanakis C; Fusai G; Bartsch D; Falconi M
    Neuroendocrinology; 2016; 103(6):779-86. PubMed ID: 26731608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.
    Lopez CL; Albers MB; Bollmann C; Manoharan J; Waldmann J; Fendrich V; Bartsch DK
    World J Surg; 2016 Jul; 40(7):1729-36. PubMed ID: 26956903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
    Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J
    Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
    Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
    Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
    Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
    Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort.
    van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR;
    Br J Surg; 2020 Oct; 107(11):1489-1499. PubMed ID: 32352164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
    Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
    Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
    Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
    Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robot-assisted spleen preserving pancreatic surgery in MEN1 patients.
    Nell S; Brunaud L; Ayav A; Bonsing BA; Groot Koerkamp B; Nieveen van Dijkum EJ; Kazemier G; de Kleine RH; Hagendoorn J; Molenaar IQ; Valk GD; ; Borel Rinkes IH; Vriens MR
    J Surg Oncol; 2016 Sep; 114(4):456-61. PubMed ID: 27263513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk?
    McDonald JD; Gupta S; Shindorf ML; Copeland A; Good ML; Sadowski SM; Nilubol N
    Am J Surg; 2021 Feb; 221(2):465-471. PubMed ID: 32943182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.